The symptoms are pain in the bones, bone fractures, bone tissue formation, callus, bow legs, bluish tinge of white part of eye, scoliosis, hearing loss, enlarged head, bruising, physical deformity, stiffness or short stature. Contact us for Osteogenesis Imperfecta Treatment in India.
Osteogenesis imperfecta treatment market is also known as brittle bone disease is hereditary bone disorders characterized by frailty of bone fractures and deformities.
It is caused by impairment of collagen synthesis and structure.
Collagen is the major protein component of the extracellular matrix in the bone, tendon and skin.
The patients with osteogenesis imperfecta experience bone fracture, bluish tinge of the cornea of the eyes, bow legs and others.According to the statistics published in the National Organization for Rare Disorders, Inc, an estimated total population of osteogenesis imperfecta type I is up to 1 per 30,000 live births and the overall prevalence of all the type 0.5 in every 10,000 people in the United States.
Accelerating demand of novel therapies and huge financial support by government are the key drivers for market growthosteogenesis imperfecta treatment market is rising gradually with registering a substantial CAGR in the forecast period of 2019-2026.
The report contains data of the base year 2018 and historic year 2017.
